A Randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine: Research submission

Headache

Volumn 48, Issue 9, 2008, Pages 1286-1293

  Bigal, Marcelo ^a,b   Sheftell, Fred ^c   Tepper, Stewart ^d   Tepper, Deborah ^d   Ho, Tony W ^b   Rapoport, Alan ^e  

^a Scientific Affairs   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c NEW ENGLAND CENTER FOR HEADACHE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dexamethasone; Menstrual migraine; Menstrually related migraine; Rizatriptan

Indexed keywords

DEXAMETHASONE; RIZATRIPTAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISABILITY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; DYSPEPSIA; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MENSTRUAL MIGRAINE; MONOTHERAPY; NECK PAIN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SHOULDER PAIN; STATISTICS; THERAPY EFFECT; THORAX PAIN; TREATMENT RESPONSE;

CROSS-OVER STUDIES; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; HEADACHE; HUMANS; MENSTRUATION; TRIAZOLES; TRYPTAMINES;

EID: 53849117446     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01092.x     Document Type: Article

References (30)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001 41 : 646 657.
2. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: Results from the American Migraine Study II. Headache. 2001 41 : 638 645.
3. Bigal ME, Lipton RB, Winner P, Reed ML, Diamond S, Stewart WF AMPP Advisory Group. Migraine in adolescents: Association with socioeconomic status and family history. Neurology. 2007 69 : 16 25.
4. MacGregor EA, Frith A, Ellis J, Aspinall L. Predicting menstrual migraine with a home-use fertility monitor. Neurology. 2005 64 : 561 563.
5. Bousser MG. Estrogens, migraine, and stroke. Stroke. 2004 35 (11 Suppl. 1 2652 2656.
6. Martin VT, Lee J, Behbehani MM. Sensitization of the trigeminal sensory system during different stages of the rat estrous cycle: Implications for menstrual migraine. Headache. 2007 47 : 552 563.
7. Silberstein SD. Migraine and women. The link between headache and hormones. Postgrad Med. 1995 97 : 147 153.
8. MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology. 2006 67 : 2154 2158.
9. Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000 55 : 1517 1523.
10. Goldberg J, Wolf A, Silberstein S, et al. Evaluation of an electronic diary as a diagnostic tool to study headache and premenstrual symptoms in migraineurs. Headache. 2007 47 : 384 396.
11. Goadsby PJ, Dodick DW, Ferrari MD, McCrory DC, Williams P. TRIPSTAR: Prioritizing oral triptan treatment attributes in migraine management. Acta Neurol Scand. 2004 110 : 137 143.
12. Rapoport AM, Tepper SJ, Bigal ME, Sheftell FD. The triptan formulations: How to match patients and products. CNS Drugs. 2003 17 : 431 447.
13. Krymchantowski AV, Bigal ME. Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC Neurol. 2004 4 : 10.
14. Rozen TD. Migraine headache: Immunosuppressant therapy. Curr Treat Options Neurol. 2002 4 : 395 401.
15. Krymchantowski AV, Barbosa JS. Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug. Arq Neuropsiquiatr. 2001 59 : 708 711.
16. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edn. Cephalalgia. 2004 24 (Suppl. 1 1 15.
17. Headache I, Trials S. Guidelines for controlled trials for migraine, 2nd end. Cephalalgia. 2000 20 : 765 786.
18. MacGregor EA, Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology. 2004 63 : 351 353.
19. Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs. Neurology. 2000 55 : 1517 1523.
20. Bigal ME, Lipton RB. The epidemiology of menstrually related migraine. Current pain and headache reports ADD.
21. Lay CL, Payne R. Recognition and treatment of menstrual migraine. Neurologist. 2007 13 : 197 204.
22. Johannes CB, Linet MS, Stewart WF, Celentano DD, Lipton RB, Szklo M. Relationship of headache to phase of the menstrual cycle among young women: A daily diary study. Neurology. 1995 45 : 1076 1082.
23. Granella F, Sances G, Allais G, et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia. 2004 24 : 707 716.
24. Silberstein SD, Massiou H, Le Jeunne C, Johnson-Pratt L, McCarroll KA, Lines CR. Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol. 2000 96 : 237 242.
25. Mannix LK, Loder E, Nett R, et al. Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: Two prospective, randomized, placebo-controlled, double-blind studies. Cephalalgia. 2007 27 : 414 421.
26. Baden EY, Hunter CJ. Intravenous dexamethasone to prevent the recurrence of benign headache after discharge from the emergency department: A randomized, double-blind, placebo-controlled clinical trial. CJEM. 2006 8 : 393 400.
27. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: A race against the development of cutaneous allodynia. Ann Neurol. 2004 55 : 19 26.
28. Jakubowski M, Levy D, Kainz V, Zhang XC, Kosaras B, Burstein R. Sensitization of central trigeminovascular neurons: Blockade by intravenous naproxen infusion. Neuroscience. 2007 148 : 573 583.
29. Yarnitsky D, Goor-Aryeh I, Bajwa ZH, et al. Award: Possible parasympathetic contributions to peripheral and central sensitization during migraine. Headache. 2003 43 : 704 714.
30. Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal zolmitriptan in acute cluster headache: A randomized, placebo-controlled, double-blind crossover study. Arch Neurol. 2006 63 : 1537 1542.